Our current findings add significantly to the growing amount of knowledge regarding the EZH2:H3K27me3 axis in the contexts of malignancy and GSC phenotype regulation, and it is predicted that blocking this axis can negatively impact GBM growth. This evidence concerns the gene EZH2 and glioblastoma.